Explore: Levodopa

Levodopa, also known as L-DOPA, is a dopaminergic medication which is used in the treatment of Parkinson's disease (PD) and certain other conditions like

Carbidopa/levodopa, also known as levocarb and co-careldopa, is the combination of the two medications carbidopa and levodopa. It is primarily used to

with levodopa to mitigate these effects. Long-term levodopa use may also induce dyskinesia and motor fluctuations. Although this often causes levodopa use

l-DOPA, also known as l-3,4-dihydroxyphenylalanine and used medically as levodopa, is made and used as part of the normal biology of some plants and animals

Levodopa-induced dyskinesia (LID) is a form of dyskinesia associated with levodopa (L-DOPA), used to treat Parkinson's disease. It often involves hyperkinetic

peripheral metabolism of levodopa. This property is significant in that it allows a greater proportion of administered levodopa to cross the blood–brain

treatment of Parkinson's disease. Entacapone together with levodopa and carbidopa allows levodopa to have a longer effect in the brain and reduces Parkinson's

of 2017.[relevant?] Levodopa-induced dyskinesia (LID) is evident in patients with Parkinson's disease who have been on levodopa (L‑DOPA) for prolonged

extended-release formulation was approved for use in the treatment of levodopa-induced dyskinesia. Amantadine was initially developed to prevent replication

It also methylates levodopa. COMT inhibitors are indicated for the treatment of Parkinson's disease in combination with levodopa and an aromatic L-amino